From clinical chemistry to digital pathology: Read more about how modern medical laboratories and procedures in pathology play a vital role in the detection and prevention of diseases and in medical research.
Sakura Finetek and Hamamatsu Photonics K.K. have announced a collaboration aimed at standardising slide preparation and digitisation to support diagnostic accuracy in pathology.
Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Scientists have discovered the protective role of a bacterium that could prevent long Covid. Their discovery could lead to the development of new therapy approaches.
Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and the Atellica IM Brain Derived Tau (BDTau) assays. Both are run on the Atellica Solution IM and Atellica CI Analyzers.
Glioblastoma is notorious for late diagnosis, rapid progression, resistance to treatment and its biological complexity. A new experimental method could help detect this deadly type of brain cancer.
Antibiotics can affect the composition of the community of bacteria living in the gut, known as the gut microbiome, for as long as four to eight years after treatment, a new study shows.
Researchers discovered that pineoblastoma, retinoblastoma and medulloblastoma – severe brain tumours in children that appear to be completely different – actually arise from the same type of cell.
On March 18–19, 2026, Poznań will host the fourth edition of the Laboratory Equipment and Technology Trade Fair, Labs Expo – an event combining presentations of modern technological solutions with an intensive, content-rich conference program. This year’s agenda has been designed for practitioners, including laboratory managers, QC and R&D specialists, metrologists, auditors,…
Coronaviruses can generate new variants capable of infecting humans after circulating in animal reservoirs. Researchers develop broad-spectrum antiviral drugs to curb the spread of these pathogens.
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy, significantly reducing the chances of survival. Researchers found there is more than one way this can happen.
Pancreatic cancer remains a diagnostic challenge, due to unspecific early symptoms and lack of effective screening tools. A novel AI metabolomics platform could help overcome these issues.
“The bacteria effectively hide in a bunker”: New research reveals a surprising mechanism used by Acinetobacter baumannii and Pseudomonas aeruginosa to protect themselves from antibiotics.
Clues in the CSF: Researchers have developed the first high-precision method that can theoretically diagnose common brain tumors in children and adolescents without surgery.
A new study shows that analyzing bacteria from vaginal swab samples taken at delivery could help predict the risk of neonatal sepsis.
Selecting the healthiest embryo is one of the most important steps in in‑vitro fertilization, yet it remains one of the most uncertain. A new type of hydrogel offers hope for more successful IVF.
Due to its rapid spread in the abdomen, ovarian cancer is often only detected at an advanced stage. Now, scientists have discovered how this cancer takes advantage of other cells for metastasis.
Reseachers show how Candida albicans – a fungus living in our body – can make melanoma more aggressive. The results pave the way for antifungal therapies to complement skin cancer treatments.
Researchers report on decisive steps towards an early diagnosis of Parkinson’s disease: a newly discovered biomarker in the blood could open a window of opportunity for future treatment.
Computational pathology is becoming increasingly important in helping deliver precision medicine to a wider range of patients. Experts at the 37th European Congress of Pathology in Vienna discussed how algorithms can optimise laboratory workflows, generate stronger evidence for molecular tumour boards, and enhance clinical trial design.
A new study into the long-term health impacts of coronavirus has found changes in the blood after Covid-19 that might pinpoint patients at risk of ongoing lung disease.
Analytik Jena will be presenting new automation solutions for laboratory workflows at the SLAS 2026 International Conference & Exhibition (February 7–11). A particular highlight is the launch of the PULSEspencer R – the first model in a digital and contactless dispenser series in the company's portfolio.
Researchers have uncovered how a high-risk class of genetic vectors can efficiently spread antibiotic resistance within the gut, enabling even highly virulent bacteria to acquire drug resistance.
The Blood Transfusion service at Aneurin Bevan University Health Board (ABUHB) has implemented Clinisys WinPath LIMS, marking the first deployment of this system in Wales.
Analytical and measurement technology copany Horiba has obtained CE IVDR certification for its new Yumizen H500 CRP benchtop hematology analyzer, designed for small laboratories.
Non-specific symptoms such as fatigue, pain or weight loss can be caused by cancer, another serious condition or something completely harmless. A blood test can help provide relevant information.
